Back Back
piroxicam tablets
730 - 770 Per Box
10000 box (MOQ)
Piroxicam is a medication named a non-steroidal anti-inflammatory drug. It is usually directed to just as 'an anti-inflammatory', or occasionally as an 'NSAID'. It functions by controlling the production of some natural chemicals in your body that provoke discomfort and inflammation. The medicine can even be taken by mouth in a tablet as well as a capsules form, although different drugs are usually chosen for it. When piroxicam is used to the skin as a gel, rather than it applying all of your body, it just functions on the spot where you have applied it. This in turn indicates that you are much less possible to have a side effect on the medication.
Piroxicam
Get Price Quote
100 Kilogram (MOQ)
We are offering piroxicam ip/bp/usp. piroxicam ip/bp/usp(cas no : 36322-90-4) piroxicam is nsaid (nonsteroidal anti-inflammatory drug) of oxicam. Piroxicam used for once-a-day treatment of rheumatoid arthritis and osteoarthritis. It is a cyclooxygenase inhibitor. It shows to be effective in the chomoprevention of colon cancer. It is a white crystalline solid; sparingly soluble in water, dilute acid and organic solvents; slightly soluble in alcohols and in aqueous alkalines. product name: piroxicam synonyms: 4-hydroxy-2-methyl-n-2-pyridinyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide cas no : 36322-90-4 chemical formula: c15h13n3o4s molecular weight: 331.35 g/mol therapeutic class: nsaid specification: residue on ignition :- not more than 0.3% heavy metals:- not more than 0.002% water:- not more than 0.5% organic volatile impurities:- less than 500ppm trichloroethylene:- less than 80ppm 1,4-dioxane :- less than 100ppm benzene :- less than 2ppm assay(on dried basis):- 97.0%~103.0%
Best Deals from Piroxicam
Piroxicam Tablet
850 - 1,000 Per Box
10000 Boxes (MOQ)
Piroxicam gel is a non-steroidal anti-inflammatory drug meant for a combination of conditions indicated by discomfort and inflammation, or immobility. It is useful in the treatment of osteoarthritis of external joints including the knee, periarthritis, acute musculoskeletal injuries, tendinitis, epicondylitis and tenosynovitis. The medicine should not be provided to a condition in which aspirin and different non-steroidal anti-inflammatory drug (NSAID) cause the symptoms of nasal polyps, urticaria, angioneurotic oedema or asthma. Life-threatening cutaneous responses, such as medication responses with eosinophilia and systemic symptoms (DRESS syndrome), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been noted with the usage of systemic control of piroxicam.
